{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:00:16Z","timestamp":1792184416445,"version":"4.4.0"},"reference-count":19,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,1,14]]},"published-print":{"date-parts":[[2025,4]]},"DOI":"10.2967\/jnumed.124.268640","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T12:40:13Z","timestamp":1740055213000},"page":"579-584","source":"Crossref","is-referenced-by-count":23,"title":["Therapy-Related Myeloid Neoplasms After [\n                    <sup>177<\/sup>\n                    Lu]Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Series"],"prefix":"10.2967","volume":"66","author":[{"given":"Michal","family":"Eifer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan E.K.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Buteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun A.","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Emmett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Kostos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind S.","family":"Ravi Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond M.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Medhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahneen","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W.","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"2025040211001539000_66.4.579.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2025040211001539000_66.4.579.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00237-3"},{"key":"2025040211001539000_66.4.579.3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jmrs.227","article-title":"Lutetium 177 PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy","volume":"64","author":"Emmett","year":"2017","journal-title":"J Med Radiat Sci."},{"key":"2025040211001539000_66.4.579.4","first-page":"594","article-title":"Hematotoxicity after radioligand therapy with 177Lu-PSMA-617 in patients with metastatic prostate cancer","volume":"61","author":"Gr\u00f6ner","year":"2020","journal-title":"J Nucl Med."},{"key":"2025040211001539000_66.4.579.5","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/leu.2017.33","article-title":"Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium","volume":"31","author":"Zeidan","year":"2017","journal-title":"Leukemia."},{"key":"2025040211001539000_66.4.579.6","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/jamaoncol.2020.0078","article-title":"Assessment of therapy-related myeloid neoplasms in patients with neuroendocrine tumors after peptide receptor radionuclide therapy: a systematic review","volume":"6","author":"Sonbol","year":"2020","journal-title":"JAMA Oncol."},{"key":"2025040211001539000_66.4.579.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2009.10.009"},{"key":"2025040211001539000_66.4.579.8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jmoldx.2018.10.005","article-title":"t(3;8)(q26.2;q24) often leads to MECOM\/MYC rearrangement and is commonly associated with therapy-related myeloid neoplasms and\/or disease progression","volume":"21","author":"Tang","year":"2019","journal-title":"J Mol Diagn."},{"key":"2025040211001539000_66.4.579.9","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1158\/1078-0432.CCR-22-2998","article-title":"Early on-treatment changes in circulating tumor DNA fraction and response to enzalutamide or abiraterone in metastatic castration-resistant prostate cancer","volume":"29","author":"Tolmeijer","year":"2023","journal-title":"Clin Cancer Res."},{"key":"2025040211001539000_66.4.579.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00572-6"},{"key":"2025040211001539000_66.4.579.11","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1007\/s00259-020-05127-9","article-title":"Therapy-related myeloid neoplasm after peptide receptor radionuclide therapy (PRRT) in 1631 patients from our 20 years of experiences: prognostic parameters and overall survival","volume":"48","author":"Chantadisai","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025040211001539000_66.4.579.12","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1007\/s00259-019-04389-2","article-title":"Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide\/chemoradionuclide therapy (PRRT\/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series","volume":"46","author":"Goncalves","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025040211001539000_66.4.579.13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2001.01577.x"},{"key":"2025040211001539000_66.4.579.14","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S1470-2045(24)00440-6","article-title":"Sequential [177Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study","volume":"25","author":"Azad","year":"2024","journal-title":"Lancet Oncol."},{"key":"2025040211001539000_66.4.579.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-448068"},{"key":"2025040211001539000_66.4.579.16","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23281"},{"key":"2025040211001539000_66.4.579.17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.canep.2010.04.003","article-title":"Acute myeloid leukemia incidence following radiation therapy for localized or locally advanced prostate adenocarcinoma","volume":"34","author":"Ojha","year":"2010","journal-title":"Cancer Epidemiol."},{"key":"2025040211001539000_66.4.579.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.189712"},{"key":"2025040211001539000_66.4.579.19","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1200\/JCO.2024.42.16_suppl.3020","article-title":"Enrichment of somatic mosaic states involving DNA damage response and repair genes in patients treated with 177Lutetium [abstract]","volume":"42","author":"Kusne","year":"2024","journal-title":"J Clin Oncol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.268640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T14:06:31Z","timestamp":1743602791000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.268640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":19,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,1]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.2967\/jnumed.124.268640"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.268640","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]}}}